nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Chemotherapy for pancreatic cancer: the rise of multidrug regimens
|
Malka, David |
|
2018 |
3 |
10 |
p. 659-660 |
artikel |
2 |
Correction to Lancet Gastroenterol Hepatol 2018; 3: 593–95
|
|
|
2018 |
3 |
10 |
p. e5 |
artikel |
3 |
Drinking to death: the changing face of liver disease
|
The Lancet Gastroenterology & Hepatology, |
|
2018 |
3 |
10 |
p. 655 |
artikel |
4 |
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study
|
Malfertheiner, Peter |
|
2018 |
3 |
10 |
p. 698-707 |
artikel |
5 |
Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension
|
Qi, Xiaolong |
|
2018 |
3 |
10 |
p. 708-719 |
artikel |
6 |
Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial
|
Coelen, Robert J S |
|
2018 |
3 |
10 |
p. 681-690 |
artikel |
7 |
Future directions in therapeutic gastrointestinal endoscopy
|
Rees, Colin J |
|
2018 |
3 |
10 |
p. 663-664 |
artikel |
8 |
How should we drain malignant obstruction at the liver hilum?
|
Bridgewater, John |
|
2018 |
3 |
10 |
p. 657-658 |
artikel |
9 |
Idiopathic recurrent acute pancreatitis
|
Guda, Nalini M |
|
2018 |
3 |
10 |
p. 720-728 |
artikel |
10 |
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
|
Reni, Michele |
|
2018 |
3 |
10 |
p. 691-697 |
artikel |
11 |
New York State announces initiative to eliminate hepatitis C
|
Nelson, Roxanne |
|
2018 |
3 |
10 |
p. 666 |
artikel |
12 |
Nigeria's complicated hepatitis burden
|
Abutu, Alex |
|
2018 |
3 |
10 |
p. 669 |
artikel |
13 |
One step closer to elimination of hepatitis C in Egypt
|
Esmat, Gamal |
|
2018 |
3 |
10 |
p. 665 |
artikel |
14 |
Organ donation: presumed consent is not enough
|
The Lancet Gastroenterology & Hepatology, |
|
2018 |
3 |
10 |
p. 655 |
artikel |
15 |
Research in brief
|
Baker, Holly |
|
2018 |
3 |
10 |
p. 667 |
artikel |
16 |
Risankizumab: a game changer in Crohn's disease?
|
Gecse, Krisztina B |
|
2018 |
3 |
10 |
p. 656-657 |
artikel |
17 |
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study
|
Feagan, Brian G |
|
2018 |
3 |
10 |
p. 671-680 |
artikel |
18 |
The public health challenge of liver cancer in Mongolia
|
Znaor, Ariana |
|
2018 |
3 |
10 |
p. 660-662 |
artikel |
19 |
When clean eating goes dirty
|
Staudacher, Heidi M |
|
2018 |
3 |
10 |
p. 668 |
artikel |
20 |
William Arbuthnot Lane: kink catastrophe
|
Burki, Talha Khan |
|
2018 |
3 |
10 |
p. 670 |
artikel |